James V Caruso insider trades
Open-market stock purchases and sales by James V Caruso, Chief Executive Officer at Cellectar Biosciences, Inc, from SEC Form 4 filings since Feb 22, 2010.
Track record: 89% of 9 scored buys are up 5% or more since purchase, averaging +73%.